NCT00407056View on ClinicalTrials.gov

Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2002

Study Completion Date

June 30, 2003

Conditions
UveitisPanuveitis
Interventions
DRUG

Difluprednate Ophthalmic Emulsion

All Listed Sponsors
lead

Sirion Therapeutics, Inc.

INDUSTRY

NCT00407056 - Study of Difluprednate Ophthalmic Emulsion in the Treatment of Severe Uveitis | Biotech Hunter | Biotech Hunter